Clinical Trial Update: SGLT2 Inhibitors in Geographic Atrophy [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial is evaluating SGLT2 inhibitors for geographic atrophy, an advanced form of age-related macular degeneration, and is currently recruitin…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Age-related Macular Degeneration
• Geographic Atrophy

Drugs mentioned

• FARXIGA (dapagliflozin)
• INVOKANA (CANAGLIFLOZIN)
• Jardiance (empagliflozin)
• STEGLATRO (ertugliflozin)

Snippet

Sponsor: Washington University School of Medicine | Conditions: Retinal Degeneration, Retinal Diseases | Phase 2 | Status: RECRUITING